切换至 "中华医学电子期刊资源库"

中华普通外科学文献(电子版) ›› 2017, Vol. 11 ›› Issue (05) : 352 -356. doi: 10.3877/cma.j.issn.1674-0793.2017.05.016

所属专题: 文献

综述

经直肠超声在直肠癌治疗决策中的应用价值及进展
陈立达1, 王伟1, 谢晓燕1,(), 吕明德2   
  1. 1. 510080 广州,中山大学附属第一医院超声医学科 中山大学超声诊断与介入超声研究中心
    2. 510080 广州,中山大学附属第一医院超声医学科 中山大学超声诊断与介入超声研究中心;510080 广州,中山大学附属第一医院肝外科
  • 收稿日期:2017-05-19 出版日期:2017-10-01
  • 通信作者: 谢晓燕
  • 基金资助:
    广东省科技计划项目(2017A020215195)

Value and progress of endorectal ultrasound in the treatment decision of rectal cancer

Lida Chen1, Wei Wang1, Xiaoyan Xie1,(), Mingde Lyu2   

  1. 1. Department of Medical Ultrasonics, Institute of Diagnostic and Interventional Ultrasound, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China
    2. Department of Medical Ultrasonics, Institute of Diagnostic and Interventional Ultrasound, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China; Department of Hepatobiliary Surgery, the First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China
  • Received:2017-05-19 Published:2017-10-01
  • Corresponding author: Xiaoyan Xie
  • About author:
    Corresponding author: Xie Xiaoyan, Email:
引用本文:

陈立达, 王伟, 谢晓燕, 吕明德. 经直肠超声在直肠癌治疗决策中的应用价值及进展[J/OL]. 中华普通外科学文献(电子版), 2017, 11(05): 352-356.

Lida Chen, Wei Wang, Xiaoyan Xie, Mingde Lyu. Value and progress of endorectal ultrasound in the treatment decision of rectal cancer[J/OL]. Chinese Archives of General Surgery(Electronic Edition), 2017, 11(05): 352-356.

直肠癌是我国第五大常见的恶性肿瘤,病死率也高居第5位,近年来由于饮食习惯改变等因素发病率仍有上升。由于治疗方法的多样化,直肠癌术前准确的TNM分期对于临床制定最佳治疗方案及预后判断尤为关键。经直肠腔内超声(ERUS)是目前公认为术前评估肿瘤分期的一种快速、安全而准确的首选影像学方法。ERUS诊断直肠癌浸润深度和术后复发的准确性及敏感度均高于CT,而与MRI相当,已被临床广泛应用于辅助制定直肠癌患者的治疗方案;但对于淋巴结转移的评估准确性仍较低。近年来发展的超声新技术如超声造影、超声弹性成像及三维超声有望提高直肠癌术前分期的准确性并减少分期过高或过低的问题,具有潜在的临床应用价值。

Rectal cancer is the fifth most common malignant tumor in China, and the mortality rate is also the fifth highest. In recent years, the incidence of rectal cancer is still rising due to changes in dietary habits. Because of the variety of treatment strategies, accurate preoperative TNM staging of rectal cancer is the key to the best clinical treatment and prognosis assessment. Endorectal ultrasound (ERUS) is a fast, safe and accurate imaging method for preoperative evaluation of tumor staging for rectal cancer. For the detection of the depth of tumor invasion and recurrence of rectal cancer after operation, the diagnostic accuracy of ERUS was higher than CT, and is equivalent to MRI. ERUS has been widely used in clinical treatment decision for patients with rectal cancer. However, the diagnostic accuracy of lymph node metastasis is still low. The new ultrasound technologies, such as contrast-enhanced ultrasound, ultrasound elastography and three-dimensional ultrasonography, are expected to improve the preoperative staging of rectal cancer, and have potential values in clinical application.

[1]
Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015[J]. CA, 2016, 66(2):115-132.
[2]
Gu J, Chen N. Current status of rectal cancer treatment in China [J]. Colorect Dis, 2013, 15(11):1345-1350.
[3]
Smith JJ, Garcia-Aguilar J. Advances and challenges in treatment of locally advanced rectal cancer[J]. J Clin Oncol, 2015, 33(16):1797-1808.
[4]
Glimelius B, Tiret E, Cervantes A, et al. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up[J]. Ann Oncol, 2013, 24 Suppl 6:vi81-88.
[5]
Schmoll HJ, Van Cutsem E, Stein A, et al. ESMO Consensus Guidelines for management of patients with colon and rectal cancer: a personalized approach to clinical decision making[J]. Ann Oncol, 2012, 23(10):2479-2516.
[6]
Cho SH, Kim SH, Bae JH, et al. Prognostic stratification by extramural depth of tumor invasion of primary rectal cancer based on the Radiological Society of North America proposal[J]. AJR, 2014, 202(6):1238-1244.
[7]
Compton C, Fenoglio-Preiser CM, Pettigrew N, et al. American Joint Committee on Cancer Prognostic Factors Consensus Conference: Colorectal Working Group[J]. Cancer, 2000, 88(7):1739-1757.
[8]
Brown G. Staging rectal cancer: endoscopic ultrasound and pelvic MRI[J]. Cancer Imaging, 2008, 8 Spec No A:S43-45.
[9]
Kav T, Bayraktar Y. How useful is rectal endosonography in the staging of rectal cancer?[J]. World J Gastroenterol, 2010, 16(6):691-697.
[10]
Rafaelsen SR, Vagn-Hansen C, Sorensen T, et al. Transrectal ultrasound and magnetic resonance imaging measurement of extramural tumor spread in rectal cancer[J]. World J Gastroenterol, 2012, 18(36):5021-5026.
[11]
Fernandez-Esparrach G, Ayuso-Colella JR, Sendino O, et al. EUS and magnetic resonance imaging in the staging of rectal cancer: a prospective and comparative study[J]. Gastrointest Endos, 2011, 74(2):347-354.
[12]
Hildebrandt U, Feifel G. Preoperative staging of rectal cancer by intrarectal ultrasound[J]. Dis Colon Rectum, 1985, 28(1):42-46.
[13]
Puli SR, Bechtold ML, Reddy JB, et al. How good is endoscopic ultrasound in differentiating various T stages of rectal cancer? Meta-analysis and systematic review[J]. Ann Surg Oncol, 2009, 16(2):254-265.
[14]
Jurgensen C, Teubner A, Habeck JO, et al. Staging of rectal cancer by EUS: depth of infiltration in T3 cancers is important[J]. Gastrointest Endos, 2011, 73(2):325-328.
[15]
Waage JE, Havre RF, Odegaard S, et al. Endorectal elastography in the evaluation of rectal tumours[J]. Colorectal Dis, 2011, 13(10):1130-1137.
[16]
Lin S, Luo G, Gao X, et al. Application of endoscopic sonography in preoperative staging of rectal cancer: six-year experience[J]. J Ultras Med, 2011, 30(8):1051-1057.
[17]
Pastor C, Subtil JC, Sola J, et al. Accuracy of endoscopic ultrasound to assess tumor response after neoadjuvant treatment in rectal cancer: can we trust the findings?[J]. Dis Colon Rectum, 2011, 54(9):1141-1146.
[18]
Rafaelsen SR, Vagn-Hansen C, Sorensen T, et al. Ultrasound elastography in patients with rectal cancer treated with chemoradiation[J]. EJR, 2013, 82(6):913-917.
[19]
Garcia-Aguilar J, Hernandez de Anda E, Rothenberger DA, et al. Endorectal ultrasound in the management of patients with malignant rectal polyps[J]. Dis Colon Rectum, 2005, 48(5):910-916.
[20]
Puli SR, Bechtold ML, Reddy JB, et al. Can endoscopic ultrasound predict early rectal cancers that can be resected endoscopically? A meta-analysis and systematic review[J]. Digest Dis Sci, 2010, 55(5):1221-1229.
[21]
Gleeson FC, Clain JE, Papachristou GI, et al. Prospective assessment of EUS criteria for lymphadenopathy associated with rectal cancer[J]. Gastrointest Endos, 2009, 69(4):896-903.
[22]
Puli SR, Reddy JB, Bechtold ML, et al. Accuracy of endoscopic ultrasound to diagnose nodal invasion by rectal cancers: a meta-analysis and systematic review[J]. Ann Oncol, 2009, 16(5):1255-1265.
[23]
Lu M, Yan B, Song J, et al. Double-contrast-enhanced sonography for diagnosis of rectal lesions with pathologic correlation[J]. J Ultras Med, 2014, 33(4):575-583.
[24]
Giovannini M. Contrast-enhanced and 3-dimensional endoscopic ultrasonography[J]. Gastroenterol Clin N, 2010, 39(4):845-858.
[25]
Waage JE, Bach SP, Pfeffer F, et al. Combined endorectal ultrasonography and strain elastography for the staging of early rectal cancer[J]. Colorectal Dis, 2015, 17(1):50-56.
[26]
Murad-Regadas SM, Regadas FS, Rodrigues LV, et al. Criteria for three-dimensional anorectal ultrasound assessment of response to chemoradiotherapy in rectal cancer patients[J]. Colorectal Dis, 2011, 13(12):1344-1350.
[27]
Krajewski KM, Kane RA. Ultrasound staging of rectal cancer[J]. Semin Ultrasound CT, 2008, 29(6):427-432.
[28]
Li JC, Liu SY, Lo AW, et al. The learning curve for endorectal ultrasonography in rectal cancer staging[J]. Surg Endos, 2010, 24(12):3054-3059.
[29]
汪晓东,邓磊,刘丹, 等. 经直肠超声在直肠癌诊疗中的应用进展[J]. 医学与哲学, 2009, 30(16):44-46.
[1] 章建全, 程杰, 陈红琼, 闫磊. 采用ACR-TIRADS评估甲状腺消融区的调查研究[J/OL]. 中华医学超声杂志(电子版), 2024, 21(10): 966-971.
[2] 罗辉, 方晔. 品管圈在提高甲状腺结节细针穿刺检出率中的应用[J/OL]. 中华医学超声杂志(电子版), 2024, 21(10): 972-977.
[3] 杨忠, 时敬业, 邓学东, 姜纬, 殷林亮, 潘琦, 梁泓, 马建芳, 王珍奇, 张俊, 董姗姗. 产前超声在胎儿22q11.2 微缺失综合征中的应用价值[J/OL]. 中华医学超声杂志(电子版), 2024, 21(09): 852-858.
[4] 孙佳丽, 金琳, 沈崔琴, 陈晴晴, 林艳萍, 李朝军, 徐栋. 机器人辅助超声引导下经皮穿刺的体外实验研究[J/OL]. 中华医学超声杂志(电子版), 2024, 21(09): 884-889.
[5] 史学兵, 谢迎东, 谢霓, 徐超丽, 杨斌, 孙帼. 声辐射力弹性成像对不可切除肝细胞癌门静脉癌栓患者放射治疗效果的评价[J/OL]. 中华医学超声杂志(电子版), 2024, 21(08): 778-784.
[6] 王振宁, 杨康, 王得晨, 邹敏, 归明彬, 王雅楠, 徐明. 机器人与腹腔镜手术联合经自然腔道取标本对中低位直肠癌患者远期疗效比较[J/OL]. 中华普通外科学文献(电子版), 2024, 18(06): 437-442.
[7] 赵丽霞, 王春霞, 陈一锋, 胡东平, 张维胜, 王涛, 张洪来. 内脏型肥胖对腹腔镜直肠癌根治术后早期并发症的影响[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 35-39.
[8] 吴晖, 佴永军, 施雪松, 魏晓为. 两种解剖入路下行直肠癌侧方淋巴结清扫的效果比较[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 40-43.
[9] 周世振, 朱兴亚, 袁庆港, 刘理想, 王凯, 缪骥, 丁超, 汪灏, 管文贤. 吲哚菁绿荧光成像技术在腹腔镜直肠癌侧方淋巴结清扫中的应用效果分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 44-47.
[10] 徐逸男. 不同术式治疗梗阻性左半结直肠癌的疗效观察[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 72-75.
[11] 李代勤, 刘佩杰. 动态增强磁共振评估中晚期低位直肠癌同步放化疗后疗效及预后的价值[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 100-103.
[12] 庄宝雄, 邓海军. 单孔+1腹腔镜直肠癌侧方淋巴结清扫术[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 601-601.
[13] 严虹霞, 王晓娟, 张毅勋. 2 型糖尿病对结直肠癌患者肿瘤标记物、临床病理及预后的影响[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 483-487.
[14] 赵磊, 刘文志, 林峰, 于剑, 孙铭骏, 崔佑刚, 张旭, 衣宇鹏, 于宝胜, 冯宁. 深部热疗在改善结直肠癌术后辅助化疗副反应及生活质量中的作用研究[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 488-493.
[15] 陈杰, 武明胜, 李一金, 李虎, 向源楚, 荣新奇, 彭健. 低位直肠癌冷冻治疗临床初步分析[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(06): 494-498.
阅读次数
全文


摘要